Home › IGA Glomerulonephritis › Massachusetts › Boston
IGA Glomerulonephritis clinical trials in Boston, MA
3 studies for IGA Glomerulonephritis are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingPhase 3
- The Vasculitis and Glomerulonephritis Center at Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
RecruitingObservational study
- Novartis Investigational site, Boston
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
RecruitingPhase 2
- Clinical Research Site 369, Boston
IGA Glomerulonephritis trials in other cities
- Houston, TX9 studies
- Denver, CO5 studies
- Orlando, FL5 studies
- Sioux City, IA4 studies
- Los Angeles, CA4 studies
- New York City, NY3 studies
- Johns Creek, GA3 studies
- Philadelphia, PA3 studies
- Columbus, OH3 studies
- Cedar Rapids, IA3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.